Takeda defeats Zydus Pharmaceuticals' antitrust counterclaims in patent case over ulcer drug
MLex Summary: Zydus Pharmaceuticals has failed to show that Takeda Pharmaceutical’s patent claims against Zydus over the drug lansoprazole are baseless, according to a US judge granting Takeda’s motion for judgment....To view the full article, register now.
Already a subscriber? Click here to view full article